Intra-arterially administered vasopressin inhibits nocturnal pineal melatonin synthesis in the rat.
1. In order to investigate the possible involvement of arginine-vasopressin (AVP) in the inhibition of nocturnal pineal melatonin synthesis following electrical stimulation of the hypothalamic paraventricular nuclei, adult male rats received injections of 5 micrograms/100 g body weight of the peptide during either day- or night-time. Following survival times of 30 or 120 min, animals were killed and the activity of the melatonin synthesis enzyme N-acetyltransferase (NAT) was determined. 2. At night, NAT activity was significantly decreased 30 and 120 min following AVP injection. 3. During the daytime, NAT activity was unchanged following AVP administration. 4. It is suggested that pineal melatonin synthesis may be affected by PVN stimulation not only via neural pathways but possibly also by PVN-released blood-borne AVP.
D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology*; D002940:Circadian Rhythm; D007269:Injections, Intra-Arterial; D008297:Male; D008550:Melatonin / Q000096:biosynthesis*; D010870:Pineal Gland / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains
D001127:Arginine Vasopressin; D008550:Melatonin